Who is aptorum Group Limited?

Aptorum Group Limited (Nasdaq: APM) is a clinical stage biopharmaceutical company dedicated to the discovery, development and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases.

What did aptorum group do in 2023?

NEW YORK & LONDON, December 22, 2023--Aptorum Group Limited (NASDAQ: APM) ("Aptorum Group" or the "Company"), a clinical stage biopharmaceutical company dedicated to meeting unmet medical needs in oncology, autoimmune and infectious diseases, today provided a business update and announced financial results for the six months ended June 30, 2023.

What does aptorum stand for?

NEW YORK & LONDON, March 06, 2024 -- ( BUSINESS WIRE )--Aptorum Group Limited (Nasdaq: APM), a clinical stage biopharmaceutical company ( "Aptorum" ), and privately-held YOOV Group Holding Ltd. ( "YOOV") jointly announced today that they entered into an Agreement and Plan of Merger (as it may be amended from time to time, the "Merger Agreement" ).